Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing’s disease
Autor: | Kunling Wang, Tiehong Zhu, Qing He, Baoping Wang, Chonggui Zhu, Jin Cui, Wei Liu, Zhi-hong Gao, Shaofang Tang, Chen-lin Dai, Hui-Qi Qu, Fengao Li, Fangqiu Zheng, Zhongshu Ma, Menghua Yuan, Hongwei Jia, Hongyan Wei, Mei Zhu, Weihong Guo |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
0301 basic medicine Medicine (General) Hydrocortisone Osteoporosis Gene Expression Osteoclasts Disease Biochemistry Bone remodeling Absorptiometry Photon 0302 clinical medicine Bone Density Cushing Syndrome Bone mineral Lumbar Vertebrae Clinical Report Femur Neck General Medicine Middle Aged Cushing’s disease adrenal-dependent Cushing’s syndrome Female Procollagen Adult musculoskeletal diseases medicine.medical_specialty Osteocalcin 030209 endocrinology & metabolism Adrenocorticotropic hormone Bone and Bones Collagen Type I 03 medical and health sciences R5-920 Adrenocorticotropic Hormone Internal medicine Bone mineral density medicine Humans In patient Pituitary ACTH Hypersecretion Retrospective Studies Osteoblasts hypercortisolism business.industry Biochemistry (medical) Cell Biology Cushing's disease medicine.disease osteoporosis Peptide Fragments 030104 developmental biology Endocrinology Case-Control Studies Peptides business bone turnover markers |
Zdroj: | Journal of International Medical Research, Vol 46 (2018) The Journal of International Medical Research |
ISSN: | 1473-2300 0300-0605 |
DOI: | 10.1177/0300060517725660 |
Popis: | Objective To investigate the effects of Cushing’s disease (CD) and adrenal-dependent Cushing’s syndrome (ACS) on bone mineral density (BMD) and bone metabolism. Methods Data were retrospectively collected for 55 patients with hypercortisolism (CD, n = 34; ACS n = 21) from January 1997 to June 2014. BMD was examined in all patients, and bone turnover markers were tested in some patients. Healthy controls (n = 18) were also recruited. Results The lumbar spine and femoral neck BMD were significantly lower in the ACS and CD groups than in the control group. Lumbar BMD was significantly lower in the ACS than CD group. The collagen breakdown product (CTX) concentrations were significantly higher while the osteocalcin and procollagen type I N-terminal propeptide (PINP) concentrations were significantly lower in the ACS and CD groups than in the control group. The PINP concentration was significantly lower while the CTX concentration was significantly higher in the ACS than CD group. In the CD group only, lumbar BMD and serum adrenocorticotropic hormone had a significant positive correlation. Conclusions Bone turnover markers indicated suppressed osteoblast and enhanced osteoclast activities. PINP and CTX changes might indicate bone mass deterioration. Adrenocorticotropic hormone might be protective for lumbar BMD in patients with CD. |
Databáze: | OpenAIRE |
Externí odkaz: |